Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese population.

The pharmacogenomics journal - 1 Jun 2017

Sun J, Zhu M, Shen W, Wang C, Dai J, Xu L, Jin G, Hu Z, Ma H, Shen H

Abstract excerpt

ABCG2, CD133 and CD117 are pivotal markers of cancer stem cell, which are involved in carcinogenesis and cancer progression. The expression of these genes has been reported to be associated with the development and progression of many cancers, including non-small cell lung cancer (NSCLC). We selected and genotyped 9 potentially functional single-nucleotide polymorphisms in the 3 genes in a clinical cohort of 1001...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AC133 Antigen
Share to Adenocarcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Adenocarcinoma of Lung

Share to ATP Binding Cassette Transporter, Subfamily G, Member 2

Share to Carcinoma, Squamous Cell

Share to Kaplan-Meier Estimate

Share to Proportional Hazards Models

Share to Proto-Oncogene Proteins c-kit

Source

Identifiers

PMID: 26951883
DOI: 10.1038/tpj.2016.2

Genes

ABCG2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese population.PMID 26951883Read ↗

Polymorphisms of the stem cell marker gene CD133 are associated the clinical outcome in a cohort of Chinese non-small cell lung cancer patients.Semantic proximity Read ↗

Polymorphisms of the Stem Cell Marker Gene CD133 and the Risk of Lung Cancer in Chinese Population.Semantic proximity Read ↗

Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patientsSemantic proximity Read ↗

Prognostic implications of the EGFR polymorphism rs763317 and clinical variables among young Chinese lung cancer population.Semantic proximity Read ↗

Genetic variants in ABCG1 are associated with survival of nonsmall-cell lung cancer patients.Semantic proximity Read ↗

Polymorphisms on 8q24 are associated with lung cancer risk and survival in Han Chinese.Semantic proximity Read ↗

Genetic polymorphism ofSLC31A1is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulationSemantic proximity Read ↗

Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival.Semantic proximity Read ↗

Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population.Semantic proximity Read ↗

Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.Semantic proximity Read ↗

A microRNA-135a/b binding polymorphism in CD133 confers decreased risk and favorable prognosis of lung cancer in Chinese by reducing CD133 expression.Semantic proximity Read ↗

A Panel of Genetic Polymorphism for the Prediction of Prognosis in Patients with Early Stage Non-Small Cell Lung Cancer after Surgical Resection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.